AO
Annals On Call Podcast
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
0:00-29:55
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Publisher
Annals On Call Podcast
Link
media.acponline.org/annals/audio/a25-semaglutide-vs-dulaglutide-or-empagliflozin.mp3
Published
August 18, 2025
Duration
30 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
American College of Physicians
AO
Annals On Call Podcast
@annalsoncallpodcast
#semaglutideversusdulaglutide #empagliflozin #cardiovascularoutcomes #medicine
